<DOC>
	<DOCNO>NCT01631162</DOCNO>
	<brief_summary>The investigator assume analysis different volatile organic compound breath , use nanotechnology , investigator able identify unique respiratory signature different disease include asthma , chronic obstructive pulmonary disease ( COPD ) pulmonary hypertension .</brief_summary>
	<brief_title>The Identification Different Lung Diseases Analysis Volatile Organic Compounds Breath Samples</brief_title>
	<detailed_description>Five group patient include study ; group include 50-75 patient : Group -1 - Healthy volunteer , use control . Group -2 - Patients diagnose diastolic heart failure normal pulmonary artery pressure echocardiography . Group - 3 - Patients diagnose diastolic heart failure proportion pulmonary hypertension confirm right heart failure . Group - 4 - Patients diagnose chronic obstructive lung disease . Group- 5 Patients diagnosed asthma Demographic clinical data collect patient . Exhaled alveolar air collect test group . Samples collect use breath collection method develop accord recommendation American Thoracic Society , effectively avoids artifact systematic error . Two bag collect person test : One gas chromatograph analysis , another one analysis sensor array . In order achieve artificial nose high sensitivity towards unique breath marker patient specific disease , follow 5-phase approach . In phase-1 collect suitable breath sample patient compare patient data age-adjusted healthy control . In phase-2 analyze collect breath sample electronic nose setup . These breath sample train set . In phase-3 carry auxiliary chemical analysis , use gas-chromatography link mass spectrometry breath sample different aspect . Phase-4 aim improvement electronic nose setup conduct parallel first three phase . The main step phase include : - Improvement performance constituent sensor term sensitivity selectivity specific diseases biomarkers . The main parameter sensor improvement choice organic functionality nanomaterials composes sensor . - Optimization choice sensor array . For choose sensor physically replace , carry statistical analysis output particular sub-groups sensor array , instead output sensor . Based result gas chromatograph mass spectrometer chemical analysis , improve optimize sensor array achieve : ( ) maximum sensitivity breath biomarkers study disease stage dependent concentration profile ; ( ii ) minimum sensitivity non-disease related change chemical composition breath ( iii ) minimum sensitivity major ingredient breath , water vapor . Technically , aim good reproducibility sensor fabrication . We attempt improve separation test group sophisticate statistical treatment collect data . Towards end proof-of-concept study compare performance sensor array diagnosis accord clinical symptom . The comparison do term true positive , true negative , false positive , false negative , sensitivity specificity .</detailed_description>
	<mesh_term>Lung Diseases</mesh_term>
	<mesh_term>Lung Diseases , Obstructive</mesh_term>
	<mesh_term>Pulmonary Disease , Chronic Obstructive</mesh_term>
	<criteria>Inclusion Criteria 1 . Diagnosis asthma accord American Thoracic Society guideline . 2 . Diagnosis chornic obstructive pulmonary disease accord American Thoracic Society , guideline . 3 . Diagnosis pulmoanry hypertension accord American Thoracic Society guidelins 4 . Age1885 year old Exclusion criterion 1. know carrier infectious disease : HIV , hepatitis B , C 2. pregnancy 3 . History lung cancer</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>June 2012</verification_date>
	<keyword>Asthma</keyword>
	<keyword>COPD</keyword>
</DOC>